Multiple Sclerosis News

Labcorp and Quest Diagnostics have both announced the availability of blood-based biomarker testing for Alzheimer’s disease, one which detects glial fibrillary acidic protein and another for phosphorylated tau.

The effects of climate change break down epithelial barriers, enabling pollutants and other materials to penetrate the body and trigger or exacerbate autoimmune diseases, according to a review published in Frontiers in Science.

BOSTON — There is some evidence that cannabinoids may help with neuropathic pain, chemotherapy-induced nausea/vomiting and MS-associated spasticity, “but it’s not exactly a slam dunk,” a speaker said.

DENVER — Researchers have recruited women with multiple sclerosis for a study using a home-based telehealth intervention for cannabis use disorder, according to a poster presented at the American Academy of Neurology annual meeting.

DENVER — In adults with multiple sclerosis, obstructive sleep apnea increases brain atrophy independent of obesity, a common comorbidity, according to a poster at the American Academy of Neurology annual meeting.

DENVER – For older adults with MS and signs of cancer, treatment with immune checkpoint inhibitors was safe and prevented relapse or disease progression, according to interim research.

WEST PALM BEACH, Fla. — Spatial mapping of lesional tissue is a precise method to identify key functional interactions that may lead to successful therapeutic intervention in multiple sclerosis, according to a presenter at ACTRIMS 2024.

March is Multiple Sclerosis Awareness Month, a time to improve knowledge of and highlight the growing treatment options for progressive types of this degenerative disease.

WEST PALM BEACH, Fla. — Obesity was strongly associated with disability worsening, disease progression and declining quality of life in a cohort of adults diagnosed with multiple sclerosis, according to a presenter at ACTRIMS 2024.

WEST PALM BEACH, Fla. — Inclusion of underrepresented racial and ethnic groups, along with older patients, patients from rural areas and uninsured patients in multiple sclerosis-targeted clinical trials is likely to improve outcomes, according to a speaker.